BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22488221)

  • 1. Mechanisms of endothelial dysfunction in obesity-associated hypertension.
    Lobato NS; Filgueira FP; Akamine EH; Tostes RC; Carvalho MH; Fortes ZB
    Braz J Med Biol Res; 2012 May; 45(5):392-400. PubMed ID: 22488221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-associated hypertension: new insights into mechanisms.
    Rahmouni K; Correia ML; Haynes WG; Mark AL
    Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
    Hall JE
    Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The underlying mechanisms for development of hypertension in the metabolic syndrome.
    Yanai H; Tomono Y; Ito K; Furutani N; Yoshida H; Tada N
    Nutr J; 2008 Apr; 7():10. PubMed ID: 18416854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of obesity hypertension.
    Hall JE
    Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the sympathetic nervous system in obesity-related hypertension.
    da Silva AA; do Carmo J; Dubinion J; Hall JE
    Curr Hypertens Rep; 2009 Jun; 11(3):206-11. PubMed ID: 19442330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity and hypertension].
    Simonyi G; Kollár R
    Orv Hetil; 2013 Nov; 154(44):1736-42. PubMed ID: 24161597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to prevent the incidence of hypertension in type 2 diabetes patients].
    Murakami H; Shimamoto K
    Nihon Rinsho; 2003 Jul; 61(7):1154-60. PubMed ID: 12877077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity hypertension.
    Rocchini AP
    Am J Hypertens; 2002 Feb; 15(2 Pt 2):50S-52S. PubMed ID: 11866230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and treatment of the obesity-related arterial hypertension.
    Kolanowski J
    Acta Clin Belg Suppl; 1992; 14():18-25. PubMed ID: 1604957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.